Mizuho Securities Initiates Coverage on MDx Firms | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Mizuho Securities USA has initiated coverage of the diagnostics industry with an initial focus on the molecular diagnostics market.

The research is led by Peter Lawson, formerly an analyst with Thomas Weisel Partners.

This week, Lawson initiated coverage of several firms in the molecular diagnostics space including Beckman Coulter, Becton Dickinson, Cepheid, Gen-Probe, PerkinElmer, and Qiagen.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.